Download Files:
HEC72702
Price range: 3,152 CAD through 5,440 CAD
Products Details
Product Description
– HEC72702 is a novel Hepatitis B virus capsid inhibitor, based on clinical candidate GLS4. HEC72702 was found to display no induction of the CYP1A2, CYP3A4, or CYP2B6 enzyme at the high concentration of 10 μM.
Web ID
– T24135
Storage Temperature
– -20℃
Shipping
– Blue Ice
Molecular Formula
– C24H26BrFN4O5S
References
– Ren Q, Liu X, Yan G, Nie B, Zou Z, Li J, Chen Y, Wei Y, Huang J, Luo Z, Gu B, Goldmann S, Zhang J, Zhang Y. 3-((R)-4-(((R)-6-(2-Bromo-4-fluorophenyl)-5-(ethoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)propanoic Acid (HEC72702), a Novel Hepatitis B Virus Capsid Inhibitor Based on Clinical Candidate GLS4. J Med Chem. 2018 Jan 30. doi: 10.1021/acs.jmedchem.7b01914. [Epub ahead of print] PubMed PMID: 29381358.
CAS Number
– 1793063-59-8
Molecular Weight
– C24H26BrFN4O5S
SMILES
– C(OCC)(=O)C=1[C@@H](NC(=NC1CN2C[C@@H](CCC(O)=O)OCC2)C3=NC=CS3)C4=C(Br)C=C(F)C=C4
Pathway
– Others
Product type
– Small Compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
